Silence Therapeutics (SLN) Non-Current Receivables (2019 - 2024)
Historic Non-Current Receivables for Silence Therapeutics (SLN) over the last 2 years, with Q2 2020 value amounting to $40.9 million.
- Silence Therapeutics' Non-Current Receivables changed N/A to $40.9 million in Q2 2020 from the same period last year, while for Jun 2020 it was $40.9 million, marking a year-over-year change of. This contributed to the annual value of $5107.4 for FY2019, which is N/A changed from last year.
- Per Silence Therapeutics' latest filing, its Non-Current Receivables stood at $40.9 million for Q2 2020.
- In the past 5 years, Silence Therapeutics' Non-Current Receivables ranged from a high of $40.9 million in Q2 2020 and a low of $5142.9 during Q4 2019